Spora has developed a mycelium platform using high-performance wild fungal strains to create sustainable mycotextile materials enhanced with nanotechnology. Its first product is a mycelium-based leather alternative. The company's value proposition lies in the scalability of its production process and key consumer benefits, which include the discovery of new fungal species in highly biodiverse regions and the use of cutting-edge technology incorporating nanotechnology and CRISPR/Cas.